File Browser

PFIZER CANADA INC., ET AL v. TEVA CANADA LIMITED ET AL

Summary of T-1399-15

The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.

Federal Court Type: S. 18.1 Patented Medicines (Notice of Compliance) Regulations

Parties and Lawyers:
PartyFirmLawyer
MINISTER OF HEALTH (THE)
PFIZER CANADA INCTorys LLPSHAUGHNESSY, ANDREW M
TEVA CANADA LTD
WYETH LLC
Intellectual Property:
NameNumber
2436668

Patented Medicine: Desvenlafaxine (Medicinal ingredients are based on automated analysis and should not be relied upon.)

Decisions

NameDateParagraph
Pfizer Canada Inc. v. Teva Canada Limited 2017 FC 777Sep 22, 2017This is an application for an order pursuant to s 6 of the NOC Regulations prohibiting the Minister of Health from issuing a NOC in respect of a NOA sent by Teva to Pfizer, in respect of Canadian Patent No. 2,436,668 [668 Patent]. The 668 Patent covers the drug PRISTIQ, which is used for the treatment of depression. ... As a procedural note, this case was argued before I heard argument in Pfizer Canada Inc and Wyeth LLC v Apotex Inc and The Minister of Health, in respect of which I will deliver reasons and judgment later today, 2017 FC 774. ... In the reasons that follow I find on a balance of probabilities that Teva’s allegations of invalidity due to obviousness and inutility are not justified. Therefore, Pfizer will have its Order of prohibition, together with costs on terms the parties have agreed upon.


Appeals

The following appeals were taken from decision on this proceeding: [List of appeals is based on automated analysis and should not be relied upon.]


Docket Summary (Google Translate to English)

(56) 2021-06-17 - Ottawa
Certified French language Translation of judgment and reasons rendered on 22-SEP-2017 by The Honourable Mr. Justice Brown filed on 17-JUN-2021 pursuant to s. 20 of the Official Languages Act.
() 2019-01-25 - Ottawa
Copy of Reasons for Judgment and Judgment dated 25-JAN-2019 rendered by The Honourable Mr. Justice Webb The Honourable Mr. Justice Boivin The Honourable Mr. Justice de Montigny placed on file. Original filed on Court File No. A-283-17
(55) 2018-06-27 - Ottawa
Certified French language Translation of Public Judgment and Reasons rendered on 22-SEP-2017 by The Honourable Mr. Justice Brown filed on 27-JUN-2018 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Judgment entered in J. & O. Book, volume 1375 page(s) 11 - 12 and copy placed on file.
() 2018-05-17 - Toronto
Letter from Respondent - The Minister of Health dated 17-MAY-2018 informing the Court that the DOJ is moving to a new office on June 4, 2018 and providing their new address and counsel's new telephone number received on 17-MAY-2018
() 2017-10-04 - Ottawa
Copy of Notice of Appeal (Appeal Court File No. A-283-17 ) appealing Judgment of Justice Brown dated August 22, 2017 in Court File No. T-1399-15 filed in the Court of Appeal on 02-OCT-2017 on behalf of Appellant placed on file on 04-OCT-2017
() 2017-09-22 - Ottawa
Acknowledgment of Receipt received from both parties with respect to Public Reasons for Order (Doc. no. 54) placed on file on 22-SEP-2017
(54) 2017-09-22 - Ottawa
Reasons for Judgment and Judgment dated 22-SEP-2017 rendered by The Honourable Mr. Justice Brown Matter considered with personal appearance The Court's decision is with regard to Directions of the Court dated 30-AUG-2017 Result: THIS COURT'S JUDGMENT is that: 1. The application is granted. 2. The Minister of Health is prohibited from issuing a Notice of Compliance in respect of a Notice of Allegation sent by Teva Canada Ltd. to Pfizer Canada Inc., previously Wyeth LLC, dated July 10, 2015, in respect of Canadian Patent No. 2,436,668. 3. Teva shall pay Pfizer its costs of this application as per Schedule "A", Agreed Terms of Costs Order attached hereto, Paragraph 2 having been deleted as not applicable given the result. 4. The Parties shall have 20 days to consult with one another and advise the Court what if any portions of this Confidential Judgment and Reasons they wish redacted, failing which these reasons will become the public reasons and placed on the public file accordingly. Filed on 22-SEP-2017 Final Decision Certificate of Judgment entered in J. & O. Book, volume 1346 page(s) 133 - 134
() 2017-09-11 - Ottawa
Letter from Plaintiff dated 11-SEP-2017 proposing redactions to the Confidential Judgment and Reasons dated August 22, 2017. *** scanned to Brown, J. *** received on 11-SEP-2017
() 2017-09-20 - Ottawa
Acknowledgment of Receipt received from all parties (by fax) with respect to Confidential corrections to Reasons dated August 22, 2017 placed on file on 20-SEP-2017
() 2017-09-20 - Ottawa
Corrections to page(s) 15 24 28 31 36 38 83 86 111 120 121 130 135 146 of the Reasons of The Honourable Mr. Justice Brown that were dated 22-AUG-2017 received on 20-SEP-2017 Corrected pages sent to CONFIDENTIAL CORRECTIONS TO REASONS DATED AUGUST 22, 2017
() 2017-08-30 - Ottawa
Confirmation of successful transmission by fax on behalf of all parties with regard to the Direction dated August 30, 2017. placed on file on 30-AUG-2017
() 2017-08-30 - Ottawa
Written directions received from the Court: The Honourable Mr. Justice Brown dated 30-AUG-2017 directing that pages 149, 150 and 151 of the Confidential Judgment and Reasons now public. received at hearing on 30-AUG-2017 Confirmed in writing to the party(ies)
() 2017-08-25 - Ottawa
Letter from Minister dated 25-AUG-2017 re: In response to the Direction of the Court issued on August 25, 2017. received on 25-AUG-2017
() 2017-08-25 - Ottawa
Letter from Pfizer dated 25-AUG-2017 re: In response to the Direction of the Court rendered on August 25, 2017. received on 25-AUG-2017
() 2017-08-25 - Ottawa
Letter from Teva dated 25-AUG-2017 re: In response to the Direction of the rendered on August 25, 2017. received on 25-AUG-2017
() 2017-08-25 - Ottawa
Acknowledgment of Receipt received from Ms. Mantini for Pfizer, Mr. Abdulla for Teva and Mr. Lwin for the Minister with respect to Direction ID 125, by email. placed on file on 25-AUG-2017
() 2017-08-25 - Ottawa
Written directions received from the Court: The Honourable Mr. Justice Brown dated 25-AUG-2017 directing that "The parties have until close of business today to give reasons why the one page "Judgment", plus Schedule A regarding costs, should not be made public effective immediately." placed on file on 25-AUG-2017 Confirmed in writing to the party(ies)
() 2017-08-22 - Ottawa
Acknowledgment of Receipt received from Ms. Mantini for Pfizer, Mr. Abdulla for Teva and Mr. Lwin for the Minister with respect to doc. no. 53, by email. placed on file on 22-AUG-2017
(53) 2017-08-22 - Ottawa
Confidential Judgment and Reasons dated 22-AUG-2017 rendered by The Honourable Mr. Justice Brown Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: CONFIDENTIAL Filed on 22-AUG-2017 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1344 page(s) 43 - 45 Final Decision
() 2017-07-21 - Ottawa
Covering letter from Respondent dated 21-JUL-2017 concerning Doc. Nos. 51 52 placed on file on 21-JUL-2017
(52) 2017-07-21 - Ottawa
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of doc.51 upon all parties by email on 21-JUL-2017 filed on 21-JUL-2017
(51) 2017-07-21 - Ottawa
Supplemental Reply Submissions and 2 USB Keys pursuant to the amended Direction of the Court dated 6-July-2017 from the Respondent Teva Canada Limited filed on 21-JUL-2017
(50) 2017-07-21 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc 48 and 49 upon Respondent by courier on 21-JUL-2017 filed on 21-JUL-2017
(49) 2017-07-21 - Toronto
Envelope containing 3 USB keys all sent to Ottawa filed on 21-JUL-2017
() 2017-07-21 - Toronto
Letter from Applicant dated 21-JUL-2017 This letter has a USB password attached received on 21-JUL-2017
(48) 2017-07-21 - Toronto
Sealed envelope pursuant to Protective order dated 07-DEC-2015 on behalf of Applicant purporting to contain Reply Written Submissions of the Applicants regarding 2017 SCC 36 Filed on 21-JUL-2017
() 2017-07-17 - Toronto
USB Key containing a hperlinked copy of the Applicant's CONFIDENTIAL Written Submissions re: Astrazeneca v. Apotex, 2017 SCC 36 received on 17-JUL-2017
(47) 2017-07-17 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc. 46 upon Respondent Teva Canada Limited by email and courier on 17-JUL-2017 confirming service Doc. 46 upon Respondent The Minister of Health by courier on 17-JUL-2017 filed on 17-JUL-2017
(46) 2017-07-17 - Toronto
Sealed envelope pursuant to Protecetive Order on behalf of Applicant purporting to contain Written Submissions of the Applicants regarding Astrazeneca v. Apotex, 2017 SCC 36 Filed on 17-JUL-2017
() 2017-07-17 - Ottawa
Covering letter from Repondent (Teva Canada Limited) dated 17-JUL-2017 concerning confidential supplemental submissions, USB and Book of authorities placed on file on 17-JUL-2017
(45) 2017-07-17 - Ottawa
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of Confidential Supplemental Submissions of Teva Limited and Tev's supplemental Book of Authorities, USB upon applicants by by e-mail and by Hand on 17-JUL-2017 confirming service Confidential supplemental Submissions of Teva Limited and Teva's supplemental Book of Authorities and USB upon Respondent (Minister of Health) by e-mail on 17-JUL-2017 filed on 17-JUL-2017
() 2017-07-17 - Ottawa
Sealed envelope pursuant to the Order of the Court dated December 7, 2015 on behalf of Respondent (Teva Canada Limited) purporting to contain 2 Confidential USB Received on 17-JUL-2017
() 2017-07-17 - Ottawa
Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Respondent (Teva Canada Limited) received on 17-JUL-2017
(44) 2017-07-17 - Ottawa
Sealed envelope pursuant to the Order of this Court dated December 7, 2015. on behalf of Respondent (Teva Canada Limited) purporting to contain Supplemental Submissions of Teva Canada Limited pursuant to the amended direction of Mr. Justice Brwon dated July 6, 2017. Filed on 17-JUL-2017
() 2017-07-06 - Ottawa
Amended Direction "Justice Brown asks the parties to file written submissions limited to 8 pages each concerning the decision of the SCC in AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36. The submissions should be filed in the usual way, and in addition the Court requests a USB hyperlinked to any material or authorities referred to containing the argument in Word, not pdf, asap. The Court would like to have the submissions of each party by Monday close of business July 17, 2017. Each may file a 3 page reply by noon Friday, July 21". placed on file on 06-JUL-2017
() 2017-06-30 - Ottawa
AMENDED oral direction Justice Brown asks the parties to file revised written submissions limited to 8 pages each on the issue of utility havin regard to the decision of the Supreme Court of Canada today in Astrazeneca Canada Inc. v. Apotex Inc., 2017 SCC 36. The submissions should be filed inthe usual way, and in addition the Court requests a USB hyperlinked to any material or authorities referred to. The Court would like to have the submissions of each party by Wednesday, July 12, 2017. Each may file a brief reply by close of business Tuesday July 18, 2017. The Court apologizes for error in due dates. placed on file on 30-JUN-2017
() 2017-06-30 - Ottawa
Oral directions received from the Court: The Honourable Mr. Justice Brown dated 30-JUN-2017 directing that Justice Brown asks the parties to file revised submissions limited to 8 pages each on the issue of utility having regard with the decision of the Supreme Court of Canada today in Astrazeneca Canada Inc. v. Apotex Inc., 2017 SCC 36. The submissions should be filed in the usual way, and in addition the Court requests a USB hyperlinked to any material or authorities referred to. The Court wo uld like to have the submissions of each party by Monday close of business July 17,2017. Each may file a reply by noon Friday July 21. placed on file on 30-JUN-2017 Confirmed in writing to the party(ies)
() 2017-06-07 - Ottawa
Letter from the Applicants with consent of the Respondent dated 07-JUN-2017 further to the Court's request for confirmation that the parties have agreed to the enclosed terms of a Costs Order to be made in conjunction with the order dtermining the outcome of the application. received on 07-JUN-2017
() 2017-05-04 - Ottawa
Communication to the Court from the Registry dated 04-MAY-2017 re: Doc ID 100, 101 & 102 sent to Court further to the Court's direction of April 18, 2017.
() 2017-04-28 - Ottawa
Covering letter from Teca Canada Limited dated 28-APR-2017 concerning Doc. Nos. 42 43 placed on file on 28-APR-2017
(43) 2017-04-28 - Ottawa
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of the Supplemental Reply Submissions of Teva Canada Limited upon the Applicant PFIZER CANADA INC. and WYETH LLC by telecopier on 28-APR-2017 confirming service the Supplemental Reply Submissions of Teva Canada Limited upon Respondent, the Minister of Health by telecopier on 28-APR-2017 filed on 28-APR-2017
(42) 2017-04-28 - Ottawa
Written Supplementary Reply Submissions of Teva Canada Limited on behalf of Respondent (Teva Canada Limited) concerning further to the Direction of the Court dated April 18, 2017 filed on 28-APR-2017
() 2017-04-26 - Toronto
Covering letter from Applicant dated 26-APR-2017 concerning Doc 40 & USB Keys (x 2---for the JUDGE ONLY); USB with judge's copy of letter only placed on file on 26-APR-2017
(41) 2017-04-26 - Toronto
Solicitor's certificate of service on behalf of Rachael Saab confirming service of doc 40 upon all parties by telecopier on 26-APR-2017 filed on 26-APR-2017
() 2017-04-27 - Ottawa
Covering letter from Applicant dated 26-APR-2017 concerning Doc. No. 40 placed on file on 27-APR-2017
(40) 2017-04-26 - Toronto
Written Responding Supplemental Subs. of the Applicants (re: BMS v Teva FCA 76) on behalf of Applicant concerning Direction of the Court 18-APr-2017 filed on 26-APR-2017
() 2017-04-25 - Ottawa
Communication to the Court from the Registry dated 25-APR-2017 re: ID 91 sent to Court further to oral direction dated April 18, 2017
() 2017-04-21 - Ottawa
Transcript of hearing held at Toronto on 03-APR-2017 received on 21-APR-2017 Sent directly to presiding Judge 816 pages (including covering pages).
() 2017-04-21 - Ottawa
Covering letter from Respondent - Teva Canada Ltd. dated 21-APR-2017 concerning Doc. Nos. 38 39 placed on file on 21-APR-2017
(39) 2017-04-21 - Ottawa
Solicitor's certificate of service on behalf of Alee Abdulla confirming service of doc. #38 upon Applicants by telecopier on 21-APR-2017 confirming service doc. #38 upon Respondent - the Minister of Health by telecopier on 21-APR-2017 filed on 21-APR-2017
(38) 2017-04-21 - Ottawa
Supplemental Submissions on behalf of Respondent - Teval Canada Ltd. in response to Direction of the Court dated April 18, 2017 Filed on 21-APR-2017
() 2017-04-18 - Ottawa
Acknowledgment of Receipt received from parties with respect to Oral Directions placed on file on 18-APR-2017
() 2017-04-18 - Ottawa
Oral directions received from the Court: The Honourable Mr. Justice Brown dated 18-APR-2017 directing that "In response to correspondence received from the parties Pfizer and Teva, the Court requests written argument with respect to the FCA's decision in Bristol-Meyers Squibb Canada v. Teva Canada Limited, 2017 FCA 76, limited to three pages from each party, the respondent Teva to file on or before April 21, and Pfizer to file its response on or before April 26, with Teva to have a one page reply on or before April 28, 2017. The parties are to file their submissions in machine readable formal, including Word, and Pfizer is also to file its letter of March 24, 2017 in machine readable format including Word". placed on file on 18-APR-2017 Confirmed in writing to the party(ies)
() 2017-04-13 - Ottawa
Letter from Applicant dated 13-APR-2017 Further to the letter from Counsel to the Respondent and the Direction of Justice Brown dated April 12, 2017, the Applicant has no objection to the filing of brief written submissions received on 13-APR-2017
() 2017-04-13 - Ottawa
Acknowledgment of Receipt received from parties with respect to Direction placed on file on 13-APR-2017
() 2017-04-13 - Ottawa
Written directions received from the Court: The Honourable Mr. Justice Brown dated 12-APR-2017 directing that The Applicant to provide his position on the Respondent's position regarding filing of brief written argument with respect to the FCA's decision in A-191-16 placed on file on 13-APR-2017 Confirmed in writing to the party(ies)
() 2017-04-11 - Ottawa
Letter from the Respondent Teva Canada Limited dated 11-APR-2017 "...Teva would like to know if the Court would appreciate receiving a brief written argument relating to the importance and application of the Federal Court Appeal's decision..." received on 11-APR-2017
() 2017-04-07 - Toronto
Sealed envelope pursuant to Order of 7-DEC-2015 on behalf of Applicant purporting to contain Applicants' Compendium s. 53 of the Patent Act Received on 07-APR-2017
() 2017-04-07 - Toronto
Sealed envelope pursuant to Order of 5-DEC-2015 on behalf of Respondent (Teva) purporting to contain Respondent's Compendium Selection & Utility received at hearing on 07-APR-2017
() 2017-04-07 - Toronto
Sealed envelope pursuant to Order of 5-DEC-2015 on behalf of Respondent (Teva) purporting to contain Outline of Selection & Utility Argument received at hearing on 07-APR-2017
() 2017-04-05 - Toronto
Supplementary Book of Authorities consisting of 1 volume(s) on behalf of Respondent (Teva) received on 05-APR-2017
() 2017-04-05 - Toronto
Sealed envelope pursuant to Order of 5-DEC-2015 on behalf of Respondent (Teva) purporting to contain Respondent's Compendium ---Opening & Obviousness received at hearing on 05-APR-2017
() 2017-04-05 - Toronto
Sealed envelope pursuant to Order dated 5-DEC-2015 on behalf of Respondent (Teva) purporting to contain Outline of Obviousness Argument received at hearing on 05-APR-2017
() 2017-04-04 - Toronto
Sealed envelope pursuant to Order of 7-DEC-2017 on behalf of Applicant purporting to contain Applicants' Compendium (Utility) 2 VOL received at hearing on 04-APR-2017
() 2017-04-04 - Toronto
Outline of Arugment (Utility) received at hearing on 04-APR-2017
() 2017-04-03 - Toronto
Sealed envelope pursuant to Order of 7-DEC-2015 on behalf of Applicant purporting to contain Applicant's Compendium (Opening & Obviousness) 2 VOL Received on 03-APR-2017
() 2017-04-03 - Toronto
Outline of Argument (Opening & Obviousness) received at hearing on 03-APR-2017
() 2017-04-03 - Toronto
Toronto 03-APR-2017 BEFORE The Honourable Mr. Justice Brown Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Lisa Tirado Duration per day: 03-APR-2017 from 09:35 to 04:37 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Christine McCullough 04-APR-2017 from 09:20 to 04:41 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Christine McCullough 05-APR-2017 from 09:19 to 04:49 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Christine McCullough 06-APR-2017 from 09:20 to 04:32 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Christine McCullough 07-APR-2017 from 09:20 to 04:30 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Christine McCullough Total Duration: 5d Appearances: Andrew Shaughnessy / Nicole Mantini / Andrew Bernstein / Rachael Saab (416) 865-0040 representing Applicant Brian Norry / Aleem Abdulla (613) 903-5107 representing Respondent (Teva) Court Reporter: Sandra Brereton (ASAP Reporting) 416-891-8720 3-APR-2017 to 07-APR-2017 Transcript requested (on an expedited basis) Comments: DARS used at hearing ID docs: 75-84 received at hearing Minutes of Hearing entered in Vol. 972 page(s) 361 - 383 Abstract of Hearing placed on file
(37) 2017-03-31 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Supplementary Book of Authorities upon Applicant by electronically and same-day courier on 31-MAR-2017 filed on 31-MAR-2017
() 2017-03-31 - Toronto
Supplementary Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 31-MAR-2017
() 2017-03-31 - Toronto
Book of Authorities consisting of 2 volume(s) on behalf of Applicant received on 31-MAR-2017
() 2017-03-30 - Ottawa
Letter from Applicant dated 29-MAR-2017 enclosing 2 USB keys containing an updated Word version of Pfizer's confi- dential memorandum of fact and law hyperlinked to the compendium (password protected) received on 30-MAR-2017
() 2017-03-24 - Ottawa
Letter from Applicant dated 24-MAR-2017 consenting to the filing of the public version of the Respondent's Applica- tion Record received on 24-MAR-2017
() 2017-03-24 - Ottawa
Covering letter from Respondent dated 24-MAR-2017 concerning Doc. No. 36 placed on file on 24-MAR-2017
(36) 2017-03-22 - Ottawa
PUBLIC APPLICATION RECORD Number of copies received/prepared: 3 on behalf of Respondent filed on 22-MAR-2017 Document placed in Annexes J Y
() 2017-03-27 - Ottawa
Communication to the Court from the Registry dated 27-MAR-2017 re: can we accept for filing the Public Application Record of Teva Canada Limited received on March 24, 2017?
() 2017-03-24 - Ottawa
Letter from Applicant dated 24-MAR-2017 re: Further to the Case management teleconference held on March 14, 2017. (Scanned to Brown, J.) received on 24-MAR-2017
(35) 2017-03-24 - Ottawa
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of Teva's Public version of its Application Record upon all parties by email on 24-MAR-2017 filed on 24-MAR-2017
() 2017-03-17 - Ottawa
Letter from Teva Canada Limited dated 17-MAR-2017 enclosing two USB keys containing Teva's confidential memorandum (one copy with one USB key sent to presiding judge) received on 17-MAR-2017
(34) 2017-03-17 - Ottawa
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of doc. 33 upon all parties by email, on consent on 17-MAR-2017 filed on 17-MAR-2017
(33) 2017-03-17 - Ottawa
Sealed envelope pursuant to Confidentiality Order of the Court on behalf of Teva Canada Limited purporting to contain Condidential compendium of the respondent Filed on 17-MAR-2017
(32) 2017-03-16 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of applicants confidential compendium upon Respondent by courier on 16-MAR-2017 filed on 16-MAR-2017
() 2017-03-16 - Toronto
Sealed envelope pursuant to protective order dated 07-dec-2015 on behalf of Applicant purporting to contain Applicants confidential compendium 2 volumes Received on 16-MAR-2017
() 2017-03-16 - Toronto
Letter from Applicant dated 16-MAR-2017 attching usb key containing hyperlinked version of the factum with an envelope addressed to Brown J containing the password received on 16-MAR-2017
() 2017-03-13 - Toronto
Memorandum to file from Toronto dated 13-MAR-2017 Concerning letter dated 13-Mar-2017,Volume 26,doc.25 submitted this date, the Court has received a copy of this document prior to hearing 14-Mar-2017. placed on file.
() 2017-03-13 - Toronto
Letter from Applicant dated 13-MAR-2017 Further to discussion...please find 3 copies,volume 26 Applicants Confidential Application Record. received on 13-MAR-2017
() 2017-03-14 - Ottawa
Ottawa 14-MAR-2017 BEFORE The Honourable Mr. Justice Brown Language: E Before the Court: Case Management Conference Result of Hearing: parties will serve and file a Compendium by Friday or by the beginning of next week with a USB key held in chambers Duration per day: 14-MAR-2017 from 11:00 to 11:28 Courtroom : Judge's Chambers - Ottawa Court Registrar: Laurence Bélanger Total Duration: 28 min Appearances: Ms. Shaughnessy and Mrs. Mantini 416-865-8171 representing Applicant Bryan Norrie 613-903-5107 representing Respondent Minutes of Hearing entered in Vol. 971 page(s) 225 - 230 Abstract of Hearing placed on file
() 2017-03-07 - Ottawa
Confirmation of successful fax transmission received from all parties with respect to id#53 placed on file on 07-MAR-2017
() 2017-03-07 - Ottawa
Oral directions received from the Court: The Honourable Mr. Justice Brown dated 07-MAR-2017 directing that "A Case Management Conference will take place in this matter on March 14, 2017, from 11:00AM to 12:00 PM". placed on file on 07-MAR-2017 Confirmed in writing to the party(ies)
() 2017-02-21 - Ottawa
Covering letter from the Respondent - Teva Canada Limited dated 21-FEB-2017 concerning doc.30+ Doc.31 ID.# 51 placed on file on 21-FEB-2017
() 2017-02-21 - Ottawa
Book of Authorities consisting of 3 volume(s) on behalf of the Respondent - Teva Canada Limited received on 21-FEB-2017 Sent directly to Presiding Judge
(31) 2017-02-21 - Ottawa
Affidavit of service of Aleem Abdulla sworn on 21-FEB-2017 on behalf of Respondent Teva Canada Limited confirming service of Doc.30 and ID.51 upon the Applicants, and the Respondent - Minister of Health by by email and by sending hard copies by courier on 21-FEB-2017 filed on 21-FEB-2017
(30) 2017-02-21 - Ottawa
Sealed envelope pursuant to Protective Order dated 7-Dec-2015 on behalf of Respondent- Teva Canada limited purporting to contain Memorandum of Fact and Law of Teva Canada limited Filed on 21-FEB-2017
() 2017-02-20 - Toronto
Oral directions received from the Court: Kevin Aalto, Prothonotary dated 20-FEB-2017 directing that the Respondent's Application record can be accepted for filing on 21-FEB-2017 placed on file on 20-FEB-2017
() 2017-02-13 - Ottawa
Letter from Respondent dated 10-FEB-2017 requesting a one-day extension of time for Teva to serve and file its Memorandum of Fact and Law on February 21, 2017, instead of February 20, 2017. The extension is requested because February 20, 2017, is the Family Day holiday in Ontario, a fact that was overlooked in the schedule communicated to the Court by letter dated November 26, 2015. received on 13-FEB-2017
() 2017-01-26 - Toronto
Acknowledgment of Receipt received from the parties (via email) with respect to order doc. 29 placed on file on 26-JAN-2017
(29) 2017-01-26 - Toronto
Order dated 26-JAN-2017 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 12-JAN-2017 Result: 1) Pfizer granted leave to file application record (confidential version) by 25-JAN-2017; 2) Pfizer at the same time shall also file a public version of their application record; 3) Teva granted leave to file confidential version of application record as well as a public version by 20-FEB-2017 Filed on 26-JAN-2017 entered in J. & O. Book, volume 1325 page(s) 1 - 3 Interlocutory Decision
(28) 2017-01-25 - Toronto
Solicitor's certificate of service on behalf of Applicant confirming service of doc.26 upon Respondent,Teva Canada;Respondent,Minister of Health by personal service on 25-JAN-2017 filed on 25-JAN-2017
(27) 2017-01-25 - Toronto
Solicitor's certificate of service on behalf of applicant confirming service of doc.25 upon respondent,Teva Canada; respondent,Minister of Health by personal service on 21-DEC-2016 filed on 25-JAN-2017
(26) 2017-01-25 - Toronto
Application Record (PUBLIC) (volumes 1-26 of 26 (Memorandum Fact in Law) Number of copies received/prepared: 2 on behalf of Applicant filed on 25-JAN-2017
(25) 2017-01-25 - Toronto
Sealed envelope pursuant to Order dated 7-Dec-2015 on behalf of Applicant purporting to contain Applicants Application Record (volumes 1-26 of 26) Filed on 25-JAN-2017
() 2017-01-25 - Toronto
Letter from Applicant dated 25-JAN-2017 For the attention of Prothonotary Aalto, case management Judge. Further to timetable proposed by parties November 26,2015, confidential Application Record (26 volumes)Book of Authorities(2 volumes)Public version of Application Record pursuant to draft order submitted January 12,2017. received on 25-JAN-2017
(24) 2016-10-07 - Toronto
Solicitor's certificate of service on behalf of NICOLE MANTINI confirming service of APPLICANTS' REPLY (RULE 306 EVIDENCE)CONF REPLY AFF OF S.SHAH & J.POLLI upon RESPONDENTS, TEVA CANADA & MINISTER OF HEALTHE by COURIER on 07-OCT-2016 filed on 07-OCT-2016
() 2016-09-27 - Toronto
Acknowledgment of Receipt received from all parties with respect to doc. 23 received by email placed on file on 27-SEP-2016
(23) 2016-09-27 - Toronto
Order dated 27-SEP-2016 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 27-SEP-2016 Result: 1. Pfizer is granted leave to serve and file as part of its Application Record the Reply Affidavits. 2. Teva is granted leave to serve the Sur-Reply Affidavits and file it as part of its Application Record if Pfizer has not already filed it as part of its Application Record, which it is hereby entitled to do. 3. This order is made without prejudice to the parties' rights to raise any objections regarding the propriety or admissibility of the Reply or Sur-Reply Affidavits to the Application Judge ar the hearing of the application. 4. Sworn copies of the affidavits referred to in paragraphs 1 and 2 above shall be served by no later than 12-OCT-2016. 5. There will be no costs of this motion. Filed on 27-SEP-2016 certified copies sent to parties entered in J. & O. Book, volume 1313 page(s) 473 - 475 Interlocutory Decision
() 2016-08-16 - Toronto
Letter from Plaintiff dated 16-AUG-2016 proposing CMC dates received on 16-AUG-2016
(22) 2016-08-02 - Toronto
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of the Expert Evidence of Teva Canada Limited upon the Applicants and Respondent, the Minister of Health by email on 28-JUL-2016 filed on 02-AUG-2016
() 2016-08-17 - Ottawa
Letter from the Respondent Teva Canada Limited dated 17-AUG-2016 confirming availability for a case management conference (scanned to CMT- Toronto) received on 17-AUG-2016
(21) 2016-07-29 - Toronto
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of Confidential Affidavits of Dr. Eugene Fiese, Dr. Fakhreddin Jamali, and Dr. Daniel Z. Leiberman upon Applicant by courier on 29-JUL-2016 confirming service Confidential Affidavits of Dr. Eugene Fiese, Dr. Fakhreddin Jamali, and Dr. Daniel Z. Leiberman upon Respondent, Minister of Health by courier on 29-JUL-2016 filed on 29-JUL-2016
(20) 2016-03-30 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Confidential Supplementary Affidavit of Diane Zimmerman (sworn 28-MAR-2016) and consent upon all respondents by email on 30-MAR-2016 filed on 30-MAR-2016
(19) 2016-03-30 - Toronto
Consent on behalf of all parties to extension of time to March 29, 2016 to serve the Supplementary Affidavit of Diane Zimmerman sworn 28-MAR-2016 filed on 30-MAR-2016
() 2016-03-30 - Toronto
Letter from Applicant dated 30-MAR-2016 enclosing proof of service and consent to supplementary R.306 evidence received on 30-MAR-2016
() 2016-03-24 - Ottawa
Acknowledgment of Receipt received from all parties (by fax) with respect to doc 18 placed on file on 24-MAR-2016
(18) 2016-03-24 - Ottawa
Order (time and place) dated 24-MAR-2016 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Toronto on 03-APR-2017 to begin at 09:30 duration: 5d language: E Filed on 24-MAR-2016 cc's sent to parties entered in J. & O. Book, volume 1296 page(s) 478 - 478 Transmittal letters placed on file
() 2016-03-17 - Ottawa
Communication to the Court from the Registry dated 17-MAR-2016 re: Sent to JA's office for a hearing date to be set down.
(17) 2016-03-14 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc 16 upon Respondents by telecopier on 14-MAR-2016 filed on 14-MAR-2016
(16) 2016-03-14 - Toronto
Requisition for hearing - Application from Applicants filed on 14-MAR-2016 Tariff Application or appeal - $50.00
() 2016-03-14 - Toronto
Letter from Applicants dated 14-MAR-2016 enclosing a requisition for hearing as per proposed timetable outlined in applicants' letter dated November 26/2016. received on 14-MAR-2016
(15) 2016-03-09 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of applicant's rule 306 material upon Respondent by courier on 09-MAR-2016 filed on 09-MAR-2016
() 2016-02-08 - Toronto
Acknowledgment of Receipt received from all parties with respect to doc. 14 received by email placed on file on 08-FEB-2016
(14) 2016-02-08 - Toronto
Order dated 08-FEB-2016 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant on consent dated 28-JAN-2016 Result: granted Filed on 08-FEB-2016 certified copies sent to parties entered in J. & O. Book, volume 1292 page(s) 228 - 230 Interlocutory Decision
() 2016-01-28 - Toronto
Covering letter from Applicant dated 28-JAN-2016 concerning Doc. No. 12 placed on file on 28-JAN-2016
(13) 2016-01-28 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc 12 & draft Order upon all parties by telecopier on 28-JAN-2016 filed on 28-JAN-2016
(12) 2016-01-28 - Toronto
Consent on behalf of all parties to the issuance of an Order in the form attached hereto as Schedule 'A'. filed on 28-JAN-2016
() 2015-12-07 - Toronto
Acknowledgment of Receipt received from all parties with respect to doc. 11 received by fax placed on file on 07-DEC-2015
(11) 2015-12-07 - Toronto
Order dated 07-DEC-2015 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 01-DEC-2015 re: Protective Order Result: granted Filed on 07-DEC-2015 certified copies sent to parties entered in J. & O. Book, volume 1285 page(s) 488 - 499 Interlocutory Decision
() 2015-12-03 - Ottawa
Acknowledgment of Receipt received from all parties with respect to Order (Doc. No. 10). placed on file on 03-DEC-2015
(10) 2015-12-03 - Ottawa
Order dated 03-DEC-2015 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: "IT IS OREDERED pursuant to Rule 383 that Prothonotary Kevin R. Aalto is assigned as Case Management Judge in this matter." Filed on 03-DEC-2015 entered in J. & O. Book, volume 1285 page(s) 317 - 317 Interlocutory Decision
() 2015-12-03 - Toronto
****** CANCELLED ****** Communication to the Court from the Registry dated 03-DEC-2015 re: IDs 9, 10, 12 sent for disposition
() 2015-12-01 - Toronto
Letter from Applicant dated 01-DEC-2015 Requesting a staus update from the Court with respect to the Applicant's letter dated 26-NOV-2015 regarding case management. Counsel is also providing dates for a CMC. with proof of service upon all parties on 01-DEC-2015 received on 01-DEC-2015
(9) 2015-12-01 - Toronto
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of doc#8 upon Respondent by telecopier on 01-DEC-2015 filed on 01-DEC-2015
(8) 2015-12-01 - Toronto
Consent on behalf of all parties to the issuance of a protective order in the form attached as schedule A filed on 01-DEC-2015
() 2015-11-26 - Toronto
Letter from Applicant dated 26-NOV-2015 Requesting an Order assigning a case management judge to the file and proposing a timetable to govern the remaining steps in the application. with proof of service upon Respondent on 26-NOV-2015 received on 26-NOV-2015
() 2015-08-28 - Ottawa
Letter from Respondent, Teva, dated 28-AUG-2015 as covering letter for Notice of Appearance and Solicitor's Certificate of Service and attaching a copy of the covering letter to Justice and Applicant and a copy of the fax transmission sheet to both parties received on 28-AUG-2015
(7) 2015-08-28 - Ottawa
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of the Respondent Teva's Notice of Appearance upon Applicant Respondent, Minister of Health, by telecopier on 28-AUG-2015 filed on 28-AUG-2015
(6) 2015-08-28 - Ottawa
Notice of appearance on behalf of Respondent, Teva Canada Ltd. filed on 28-AUG-2015
(5) 2015-08-26 - Toronto
Affidavit of service of Ray Patykewich sworn on 26-AUG-2015 on behalf of Applicant confirming service of Doc 1 upon Respondent by personal service on 25-AUG-2015 filed on 26-AUG-2015
(4) 2015-08-26 - Toronto
Affidavit of service of James Adeney sworn on 26-AUG-2015 on behalf of Respondent confirming service of doc#3 upon Applicant Respondent by telecopier on 26-AUG-2015 with Exhibits A filed on 26-AUG-2015
(3) 2015-08-26 - Toronto
Notice of appearance on behalf of Respondent filed on 26-AUG-2015
(2) 2015-08-25 - Toronto
Service copy of Doc. No. 1 with proof of service upon Respondent The Minister of Health on 25-AUG-2015 filed on 25-AUG-2015
(1) 2015-08-24 - Toronto
Notice of application and 2 copies with regard to Intellectual Property filed on 24-AUG-2015 Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes

The official version of the court proceeding information is available from the court websites directly:
Browse another proceeding. Enter Court File No:

Canadian Intellectual Property